Sorry, you need to enable JavaScript to visit this website.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis (OCTAVE)

A Multi-Center, Open-Label Study of CP-690,550 in Participants With Moderate to Severe Ulcerative Colitis

Category & Conditions: Immune System Diseases and Conditions
Medicine: Xeljanz (tofacitinib) Identifier (NCT): NCT01470612
Protocol ID: A3921139
Open Plain Language Summary Result: Click here